For several decades the Texas Biomed board has provided crucial leadership to the Institute, forging incredible progress that continues to this day.
Since 2000, Texas Biomed has been at the forefront of studying deadly pathogens and testing vaccines and treatments against them, including anthrax and Ebola virus. Today, the Institute is an internationally recognized partner in defending the nation and world from potential biological threats.
Jamo Rubin, M.D., has led the Texas Biomed Board of Trustees through a historic time and now passes the leadership baton to H-E-B President Craig Boyan.
The first major capital construction project envisioned under Texas Biomed’s 10-year Strategic Plan is complete, and plans are underway for further expansion this year.
Texas Biomed was proud to host the 6th Texas Tuberculosis Research Symposium in April.
Texas Biomed has joined a unique public health collaboration with The Carter Center aimed at eradicating the painful parasitic disease caused by Guinea worm in Ethiopia.
Texas Biomed and the Southwest National Primate Research Center (SNPRC) held a groundbreaking ceremony for the new Animal Care Complex in December 2021